Neoplasia/BPH

	Stereotactic Body Radiation Therapy in Oligometastatic Castration-resistant Prostate Cancer: Time to Move from Signals to Phase 3 Trial Evidence. Eur Urol Pasquier D, Flippot R, Fizazi K, PEACE-8 investigators. PMID: 42816309 [PubMed - as supplied by publisher]
	Re: [(177)Lu]Lu-PSMA-617 in Patients with PSMA-positive Metastatic Androgen Pathway Modulator-naive/sensitive Prostate Cancer (PSMAddition): A Phase 3 Randomised, Controlled Trial. Eur Urol Viti A, Cucchiara V, Gandaglia G, Briganti A, Montorsi F. PMID: 42816307 [PubMed - as supplied by publisher]
	Intermittent fasting versus continuous calorie energy reduction in prostate cancer patients on active surveillance. Transl Behav Med Yeary KHK, Yu H, Hussein AA, Varady K, DiCarlo E, Escaldi A, Tang L. PMID: 42816069 [PubMed - indexed for MEDLINE]
	Prostate cancer screening: Evidence uncertainty and implications for patient education and counseling. Patient Educ Couns Takahashi T. PMID: 42815281 [PubMed - as supplied by publisher]
	Ethnic and Geographic Variation in Prostate Cancer Presentation in Suriname. JCO Glob Oncol Wielzen HA, Sandel NJ, Ramsoekh A, Baktawar S, Chan M, Vis AN, Pigot GLS. PMID: 42814916 [PubMed - indexed for MEDLINE]
	Patients' and Physicians' Perceptions of AI Integration in Prostate Cancer Diagnosis: Mixed Methods Study of Challenges to the Patient-Physician Relationship. J Med Internet Res Koshmanova E, Kirkove D, Voz B, Gillain N, Matagne A, Bruwier L, Waltregny D, Pétré B. PMID: 42814749 [PubMed - indexed for MEDLINE]
	Immunometabolic effects of oral testosterone for castration-resistant prostate cancer in the ACROBAT trial. Mol Cancer Res Zipkowitz S, Redinger K, Jonnatan S, Vakkala V, Lu J, Schultz K, Rifkind I, Michalik A, King S, McIntyre K, Sinibaldi V, Markowski MC, Marshall CH, Paller CJ, Wang H, Mao SS, Denmeade SR, Sanin DE, Thompson EA, Sena LA. PMID: 42814510 [PubMed - as supplied by publisher]
	Defining the Role of Single-Port Robotic Partial Nephrectomy: Current Evidence, Patient Selection, and Anatomy-Platform Matching. Curr Urol Rep Hevia V, Sánchez-Carpena J, Cámara-Martínez C, Lista-Mateos F. PMID: 42814206 [PubMed - indexed for MEDLINE]
	[Small renal tumors in geriatric patients-surveillance, biopsy, or surgery?]. Urologie Stein J, Wiedemann A, Manseck A, Blanchard K, Fiebig C, Piotrowski A, Butea-Bocu M. PMID: 42814172 [PubMed - as supplied by publisher]
	Impact of Acute Urinary Retention on the Early and Late Outcomes of Transurethral Resection of the Prostate. Niger J Clin Pract Akta, Tongal A, Gökcan AN, Köse M, Tunçekin A, Türk H. PMID: 42813874 [PubMed - indexed for MEDLINE]
	Adult intratesticular splenogonadal fusion simulating testicular cancer: a diagnostic blind spot in modern urologic oncology. J Surg Case Rep El Nabbout G, Kowalczyk JJ, Manahan KJ. PMID: 42813151 [PubMed]
	Missed Diagnosis of Clear Cell Renal Cell Carcinoma on Noncontrast Computed Tomography: The Potential Role of Artificial Intelligence in Reducing Radiological Diagnostic Error. Case Rep Nephrol Abenavoli FM, Tujjar O, Alfonso A. PMID: 42813057 [PubMed]
	Salvage Metastasis-Directed Therapy Without Androgen Deprivation for Positron Emission Tomography-Defined Oligorecurrent Prostate Cancer: Results of the SOAR Phase II Trial. JU Open Plus Crockett E, Schmidt B, Rodriguez O, Taylor A, Braun E, Leonhart S, Swami U, Boucher KM, Chapman L, Davis H, Linton J, Mangelson E, Johnson S, Tward J, Odei B, Yap J, Gupta S, Kohli M, Agarwal N, Dechet C, O'Neil B, Maughan BL, Sanchez A. PMID: 42812884 [PubMed]
	Unravelling therapeutic resistance: role of cancer stem cell and microRNA in metastatic prostate cancer. Front Mol Biosci Moondra H, Choudhary GR, Ahirwar DK, Banerjee M, Shukla SK, Shukla KK. PMID: 42812781 [PubMed]
	PROK1 Expression Is Associated With Prognosis and May Influence Response to Antiandrogen Therapy in Prostate Cancer. Prostate Cancer Lu DJ, Liang HQ, Li YJ, Yu JY, Wei LW, Mo QZ, Zhao JW, Nong RJ, Wang YY, Zhang XP, Qin M, Cheng JW. PMID: 42812728 [PubMed]
	BRCA-Mutated Prostatic Adenocarcinoma: A Distinct Clinicopathological Subset With Frequent Cribriform Morphology Associated With Domain-Specific Alterations in Putative Protein Properties. Front Biosci (Schol Ed) Kurt S, Krishnamurthy K. PMID: 42812039 [PubMed - indexed for MEDLINE]
	Label-free optical biomarker for prostate cancer diagnosis. Mol Med Alam SR, Siller K, Dreicer R, Periasamy A. PMID: 42811292 [PubMed - indexed for MEDLINE]
	Clinical utility of endorectal balloons in prostate cancer external beam radiotherapy: a systematic review and meta-analysis. Radiat Oncol J Kim YL, Yu JI, Suh JK. PMID: 42810974 [PubMed]
	Androgen Deprivation Therapy (ADT) and Radiotherapy (RT) with Imaging Evaluation Longitudinally (ARIEL) trial: protocol, early results, and implications of neoadjuvant ADT for focal RT boost in prostate cancer. Pract Radiat Oncol Song Y, Domingo MR, Nguyen L, Conlin CC, Dhillon N, Do S, Dornisch A, Hahn ME, Karunamuni R, Kim J, Lee KL, Liu J, McKay RR, Mell LK, Mundt AJ, Patel R, Qiao EM, Rose B, Rupareliya R, Schaub H, Schwartzman A, Stewart T, Dale AM, Seibert TM, ARIEL investigators. PMID: 42810618 [PubMed - as supplied by publisher]
	Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study. Ann Oncol McDermott DF, Signoretti S, Lee JL, Donskov F, Tykodi SS, Tomczak P, Bjarnason GA, Larkin JMG, Kochenderfer MD, Gafanov RA, Cristescu R, Markensohn J, Nebozhyn M, Zhang Y, Peng X, Rodriguez-Lopez K, Burgents J, Perini RF, Atkins MB. PMID: 42810586 [PubMed - as supplied by publisher]

Articles 1 - 20 / 191687

Page 1 of 9585



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy